Cargando…
Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence
Pregnant women in sub-Saharan Africa are at high risk of HIV acquisition and require effective methods to prevent HIV. In a cohort of pregnant women offered Pre-exposure prophylaxis (PrEP), we evaluate the relationship between internalized and anticipated stigma and PrEP initiation at first antenata...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294266/ https://www.ncbi.nlm.nih.gov/pubmed/34287756 http://dx.doi.org/10.1007/s10461-021-03374-x |
_version_ | 1783725198723252224 |
---|---|
author | Moran, Alexander Mashele, Nyiko Mvududu, Rufaro Gorbach, Pamina Bekker, Linda-Gail Coates, Thomas J. Myer, Landon Joseph Davey, Dvora |
author_facet | Moran, Alexander Mashele, Nyiko Mvududu, Rufaro Gorbach, Pamina Bekker, Linda-Gail Coates, Thomas J. Myer, Landon Joseph Davey, Dvora |
author_sort | Moran, Alexander |
collection | PubMed |
description | Pregnant women in sub-Saharan Africa are at high risk of HIV acquisition and require effective methods to prevent HIV. In a cohort of pregnant women offered Pre-exposure prophylaxis (PrEP), we evaluate the relationship between internalized and anticipated stigma and PrEP initiation at first antenatal visit, 3-month continuation and adherence using multivariable logistic regression. High internalized and anticipated PrEP stigma are associated with lower PrEP care initiation at first antenatal visit (aOR internalized stigma = 0.06; 95% CI = 0.03–0.11 and aOR anticipated stigma = 0.55; 95% CI = 0.31–1.00) compared to women with low reported stigma, after controlling for covariates. Women whose partners have not been tested for HIV or whose serostatus remains unknown have 1.6-times odds of PrEP retention at 3-months compared to women whose partners have been tested (aOR = 1.60; 95% CI = 1.02–2.52) after adjusting for covariates. PrEP counseling and maternal PrEP interventions must consider individual- and relational-level interventions to overcome anticipated PrEP stigma and other barriers to PrEP initiation and adherence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10461-021-03374-x. |
format | Online Article Text |
id | pubmed-8294266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-82942662021-07-21 Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence Moran, Alexander Mashele, Nyiko Mvududu, Rufaro Gorbach, Pamina Bekker, Linda-Gail Coates, Thomas J. Myer, Landon Joseph Davey, Dvora AIDS Behav Original Paper Pregnant women in sub-Saharan Africa are at high risk of HIV acquisition and require effective methods to prevent HIV. In a cohort of pregnant women offered Pre-exposure prophylaxis (PrEP), we evaluate the relationship between internalized and anticipated stigma and PrEP initiation at first antenatal visit, 3-month continuation and adherence using multivariable logistic regression. High internalized and anticipated PrEP stigma are associated with lower PrEP care initiation at first antenatal visit (aOR internalized stigma = 0.06; 95% CI = 0.03–0.11 and aOR anticipated stigma = 0.55; 95% CI = 0.31–1.00) compared to women with low reported stigma, after controlling for covariates. Women whose partners have not been tested for HIV or whose serostatus remains unknown have 1.6-times odds of PrEP retention at 3-months compared to women whose partners have been tested (aOR = 1.60; 95% CI = 1.02–2.52) after adjusting for covariates. PrEP counseling and maternal PrEP interventions must consider individual- and relational-level interventions to overcome anticipated PrEP stigma and other barriers to PrEP initiation and adherence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10461-021-03374-x. Springer US 2021-07-21 2022 /pmc/articles/PMC8294266/ /pubmed/34287756 http://dx.doi.org/10.1007/s10461-021-03374-x Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Moran, Alexander Mashele, Nyiko Mvududu, Rufaro Gorbach, Pamina Bekker, Linda-Gail Coates, Thomas J. Myer, Landon Joseph Davey, Dvora Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence |
title | Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence |
title_full | Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence |
title_fullStr | Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence |
title_full_unstemmed | Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence |
title_short | Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence |
title_sort | maternal prep use in hiv-uninfected pregnant women in south africa: role of stigma in prep initiation, retention and adherence |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294266/ https://www.ncbi.nlm.nih.gov/pubmed/34287756 http://dx.doi.org/10.1007/s10461-021-03374-x |
work_keys_str_mv | AT moranalexander maternalprepuseinhivuninfectedpregnantwomeninsouthafricaroleofstigmainprepinitiationretentionandadherence AT mashelenyiko maternalprepuseinhivuninfectedpregnantwomeninsouthafricaroleofstigmainprepinitiationretentionandadherence AT mvududurufaro maternalprepuseinhivuninfectedpregnantwomeninsouthafricaroleofstigmainprepinitiationretentionandadherence AT gorbachpamina maternalprepuseinhivuninfectedpregnantwomeninsouthafricaroleofstigmainprepinitiationretentionandadherence AT bekkerlindagail maternalprepuseinhivuninfectedpregnantwomeninsouthafricaroleofstigmainprepinitiationretentionandadherence AT coatesthomasj maternalprepuseinhivuninfectedpregnantwomeninsouthafricaroleofstigmainprepinitiationretentionandadherence AT myerlandon maternalprepuseinhivuninfectedpregnantwomeninsouthafricaroleofstigmainprepinitiationretentionandadherence AT josephdaveydvora maternalprepuseinhivuninfectedpregnantwomeninsouthafricaroleofstigmainprepinitiationretentionandadherence |